10x Genomics, Inc. (NASDAQ:TXG – Get Rating)’s stock price was up 7.2% on Friday . The stock traded as high as $55.87 and last traded at $55.79. Approximately 974,094 shares traded hands during trading, a decline of 5% from the average daily volume of 1,025,189 shares. The stock had previously closed at $52.05. Wall Street […]
Investment analysts at Stephens assumed coverage on shares of 10x Genomics (NASDAQ:TXG – Get Rating) in a research note issued to investors on Thursday, The Fly reports. The brokerage set an “overweight” rating on the stock. Other research analysts have also recently issued research reports about the company. Canaccord Genuity Group boosted their price target […]
Shares of 10x Genomics, Inc. (NASDAQ:TXG – Get Rating) have been assigned a consensus recommendation of “Hold” from the thirteen brokerages that are presently covering the company, MarketBeat Ratings reports. Two analysts have rated the stock with a sell rating, two have given a hold rating and five have issued a buy rating on the […]
10x Genomics, Inc. (NASDAQ:TXG – Get Rating) has been given a consensus recommendation of “Hold” by the thirteen brokerages that are currently covering the company, MarketBeat reports. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating and five have assigned a buy rating to the company. The […]
Advisors Asset Management Inc. trimmed its stake in 10x Genomics, Inc. (NASDAQ:TXG – Get Rating) by 2.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 20,442 shares of the company’s stock after selling 573 shares during the period. Advisors Asset Management Inc.’s holdings […]